Evaluating the Prognostic Relevance of Pre-Treatment Epstein–Barr Virus Levels in Non-Endemic Pediatric Nasopharyngeal Carcinoma
Ahmed Farrag, Yanbo Yang, Jin Piao, Lindsay Younis et autres
0 citationsCancers
Theodore W. Laetsch
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
385Publications signalées
18896Citations signalées
4Affiliations récentes
Institutions déclarées
Domaines associés
CAR-T cell therapy researchNeuroblastoma Research and TreatmentsLung Cancer Treatments and MutationsSarcoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia research
Publications récentes
Cancer control after pausing treatment with larotrectinib in responding children with sarcoma and a TRK fusion: a plain language summary
Leo Mascarenhas, C. A. Ollis, Yuvraj Singh, Linet Menachery et autres
0 citationsFuture Oncology
Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL
Stephan A. Grupp, Shannon L. Maude, Susana Rives, Hidefumi Hiramatsu et autres
0 citationsJournal of Clinical Oncology
Sustained Response to Trametinib in Central Giant Cell Granuloma With KRAS Gain-of-Function Mutation: A Case Report
Karen Huang, Rachel M. Hurley, Susan Sotardi, Portia A. Kreiger et autres
0 citationsJCO Precision Oncology
Efficacy and safety of larotrectinib in patients with non-primary central nervous system TRK fusion cancer: An updated analysis.
Alexander E. Drilon, Rui‐Hua Xu, David S. Hong, Cornelis M. van Tilburg et autres
0 citationsJournal of Clinical Oncology
Characterization and validation of a methylation signature as a prognostic marker in osteosarcoma.
Rachel M. Hurley, Cameron Cloud, Juan F. Santana, Feng Xu et autres
0 citationsJournal of Clinical Oncology
Safety and pharmacokinetics (PK) of lurbinectedin (lurbi) in pediatric patients (pts) with relapsed/refractory (R/R) solid tumors and preliminary antitumor activity in pediatric and young adult pts with R/R Ewing sarcoma (EwS): Results from a phase 1 study.
Julia Lynne Glade Bender, Joseph G. Pressey, L Wagner, AeRang Kim et autres
0 citationsJournal of Clinical Oncology
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial
Patrick J. Grohar, Rachel S. Heise, Mary Frances Wedekind, Karla V. Ballman et autres
1 citationNature Medicine
A High‐Sensitivity Circulating Nucleic Acid Sequencing Assay for Assessing Treatment Response to Alectinib in a Pediatric Patient With ALK ‐Rearranged Non–Small Cell Lung Cancer
Alberto D. Guerra, Nicholas F. Evageliou, Vandana Batra, Kristen L. Dalton et autres
0 citationsPediatric Blood & Cancer
Abstract 643: The Sean Karl Cohort: An international single-cell RNAseq study of paired patient Ewing sarcoma specimens.
Abbe Pannucci, Elina Mukherjee, Jessica Daley, Shireen Sita Ganapathi et autres
0 citationsCancer Research
Abstract 1151: Targeting high risk osteosarcoma: MYC modulation alters metastasis
Emily E. Seiden, Scott Sauer, Emma Hiscock, Nha Nhu Le et autres
0 citationsCancer Research
209P Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancer
D. Orbach, Rui Xu, C. Qi, C.M. Zwaan et autres
0 citationsESMO rare cancers.
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.